Intelligent Bio Solutions Inc. Files 8-K on Financials
Ticker: INBS · Form: 8-K · Filed: Nov 7, 2025 · CIK: 1725430
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
IBSI filed an 8-K on Nov 7th covering Nov 4th financials. Check it out.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on November 7, 2025, reporting on results of operations and financial condition as of November 4, 2025. The filing includes financial statements and exhibits, with the company's principal executive offices located at 135 West 41st Street, 5th Floor, New York, NY 10036. The company was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Why It Matters
This 8-K filing provides an update on the company's financial status and operational results, which is crucial for investors to assess its current performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- November 4, 2025 (date) — Earliest Event Reported
- November 7, 2025 (date) — Date of Report
- 135 West 41st Street, 5th Floor New York, NY 10036 (address) — Principal executive offices
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Intelligent Bio Solutions Inc., as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on November 7, 2025.
What is the earliest event date reported in this filing?
The earliest event date reported in this filing is November 4, 2025.
Where are the principal executive offices of Intelligent Bio Solutions Inc. located?
The principal executive offices of Intelligent Bio Solutions Inc. are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What were the previous names of Intelligent Bio Solutions Inc.?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-11-07 17:20:40
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-25-021323.txt ( ) — 220KB
- inbs-20251104.xsd (EX-101.SCH) — 3KB
- inbs-20251104_lab.xml (EX-101.LAB) — 33KB
- inbs-20251104_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 7, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer